Re: Josh McGuire from Rising Tide Equity
|
2
|
BIOASIS TECHNOLOGIES INC
|
Oct 25, 2016 10:57AM
|
Re: Third Eye and Topline
|
2
|
Resverlogix Corp.
|
Dec 20, 2018 02:30PM
|
Re: Win or lose....one thing we know for sure
|
2
|
Resverlogix Corp.
|
Sep 03, 2019 02:29PM
|
BIO-Europe 11/7
|
2
|
Zenith Epigenetics
|
Nov 06, 2017 10:52AM
|
Re: New Share Price Contest
|
2
|
Resverlogix Corp.
|
Oct 11, 2019 04:01PM
|
The scariest thing for a clinical trial......
|
2
|
Resverlogix Corp.
|
Oct 31, 2018 07:24PM
|
Re: Any thoughts to why BETonMACE patient median eGFR is so high?
|
2
|
Resverlogix Corp.
|
Feb 12, 2019 12:18PM
|
Re: Demoralizing....
|
2
|
Resverlogix Corp.
|
Sep 22, 2017 10:17AM
|
Re: Zenith Epigentics and Resverlogix update 22 Jan 2018
|
2
|
Resverlogix Corp.
|
Feb 01, 2018 11:39AM
|
Resverlogix Announces Closing of $15 Million Offering
|
2
|
Resverlogix Corp.
|
Jun 07, 2019 08:38AM
|
Zenith MD&A posted to SEDAR 8/23/18
|
2
|
Zenith Epigenetics
|
Aug 31, 2018 09:09AM
|
Re: Resverlogix now listed as a Presenting Company at Biopharm America
|
2
|
Resverlogix Corp.
|
Sep 22, 2017 10:26AM
|
Re: 2019 Potential Events
|
2
|
Resverlogix Corp.
|
Sep 16, 2019 04:11PM
|
Re: Excellent Discussion
|
2
|
Resverlogix Corp.
|
Jul 28, 2017 10:59AM
|
Re: Resverlogix Announces Closing of $15 Million Offering
|
2
|
Resverlogix Corp.
|
Jun 07, 2019 08:42AM
|
Re: ZEN-3694 Single Agent Trial Status
|
2
|
Zenith Epigenetics
|
Sep 22, 2017 10:30AM
|
BETonMACE Topline Results Webcast & Conference Call
|
2
|
Resverlogix Corp.
|
Sep 27, 2019 04:34PM
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 21, 2019 04:05PM
|
Re: Will we see 5 point MACE reduction results in BETONMACE
|
2
|
Resverlogix Corp.
|
Jun 15, 2019 10:35AM
|
Re: A new 52 week low, but I don't think anyone cares....
|
2
|
Resverlogix Corp.
|
Sep 24, 2019 12:36PM
|